TR
Townsend Richard Nolan
CEO
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Townsend Richard Nolan. Insider active across 1 company, notably Lexeo Therapeutics, Inc.. Cumulatively, 23 reports have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €386k. History available since 5 January 2024. The latest transaction was filed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Townsend Richard Nolan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
3,345 shares@ US$4.95120.0041% mcap2.4% of flowCommon StockSEC:0001995218-26-000015:0
55,000 shares@ US$5.693472.8% of flowCommon StockSEC:0001995218-26-000009:0
2,623 shares@ US$2.6441.5% of flowCommon StockSEC:0001995218-26-000006:0
10,173 shares@ US$6.38211.8% of flowCommon StockSEC:0001995218-26-000004:0
161,665 shares0Common StockSEC:0001995218-26-000002:0
1,127 shares@ US$9.272.2% of flowCommon StockSEC:0001995218-25-000007:0
33,000 shares0Common StockSEC:0001995218-25-000005:0
2,193 shares@ US$2.6441.2% of flowCommon StockSEC:0001995218-25-000003:0
1,115 shares@ US$4.6681.1% of flowCommon StockSEC:0001415889-25-024104:0
2,735 shares@ US$4.6682.8% of flowCommon StockSEC:0001415889-25-022473:0
1,074 shares@ US$2.7742.6% of flowCommon StockSEC:0001415889-25-013819:0
2,128 shares@ US$2.615.1% of flowCommon StockSEC:0001415889-25-009450:0
4,326 shares@ US$4.41318.0% of flowCommon StockSEC:0001415889-25-005113:0
103,750 shares0Common StockSEC:0001415889-25-001287:0
2,500 shares@ US$2.335.5% of flowCommon StockSEC:0001415889-24-029143:0
2,500 shares@ US$2.335.4% of flowCommon StockSEC:0001415889-24-026737:0
5,000 shares@ US$2.3310.5% of flowCommon StockSEC:0001415889-24-025110:0
5,000 shares@ US$2.3310.4% of flowCommon StockSEC:0001415889-24-023233:0
5,000 shares@ US$2.3310.5% of flowCommon StockSEC:0001415889-24-021245:0
5,000 shares@ US$2.3310.6% of flowCommon StockSEC:0001415889-24-019526:0
5,000 shares@ US$2.3310.7% of flowCommon StockSEC:0001415889-24-016518:0
5,000 shares@ US$2.3310.7% of flowCommon StockSEC:0000950170-24-059506:0
43,750 shares0Common StockSEC:0000950170-24-003466:0
About Townsend Richard Nolan
Townsend Richard Nolan is a declarant linked to Lexeo Therapeutics, Inc., where he is Chief Executive Officer. He has 22 filings in total, and among the recent filings tracked, the transactions shown run from 2024-01-09 to 2026-04-07, with 0 in purchases and 371449 in sales, and the most frequent transaction nature is Levée d'options.